Previous 10 | Next 10 |
Allscripts Healthcare Solutions is finally showing some robust fundamental results after a few difficult years. This is great news for investors, as is the fact that shares are cheap enough to imply some nice upside moving forward. That said, consistency is still lacking and that ...
Shares of Evolent Health (NYSE: EVH) rose more than 22% in early trading Thursday. The healthcare services stock, which closed at $22.21 on Wednesday, opened at $24.37 on Thursday and rose to a high of $27.03 in the first hour of trading. The stock has a 52-week low of $17.50 and a ...
Evolent Health (EVH +16.1%) has added more than a tenth on Thursday morning hours to record the biggest intraday gain since July 2020, after the health tech company posted better-than-expected financials for Q4 2021 and set its guidance ahead of Street forecasts. Quarterly revenue on a G...
Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...
Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q4 2021 Earnings Call Feb 23, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q4 2021 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q4 2021 Results Conference Call February 23, 2022 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Seth Frank - Vice President of Investor Relations Conference Call Participants Ryan Daniels - William Bla...
Evolent Health press release (NYSE:EVH): Q4 Non-GAAP EPS of $0.08 beats by $0.07. Revenue of $248.36M (-8.7% Y/Y) beats by $11.88M. For further details see: Evolent Health Non-GAAP EPS of $0.08 beats by $0.07, revenue of $248.36M beats by $11.88M
Evolent Health Announces Fourth Quarter and Full Year 2021 Results Announces Four New Partner Additions PR Newswire WASHINGTON , Feb. 23, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administra...
AAN, ACA, OTCPK:ACLLF, AEM, AEVA, AGI, AHT, ALLO, ALR, AMED, ANSS, ARNA, AZUL, BAND, BBDC, BBWI, BCSF, BHP, BIRD, BKNG, BMA, BMRN, CCRN, CDEV, CHDN, CHK, CLOV, CMLS, CPE, CSV, CTRA, CW, DHC, DK, DKL, EBAY, EFC, OTCPK:EIFZF, EVH, EXR, FBRT, FIVN, FIX, FLGT, FLS, FNF, FRG, FTI, FUBO, GBT, GH, G...
Evolent Health (NYSE:EVH) is scheduled to announce Q4 earnings results on Wednesday, Feb. 23, after market close. The consensus EPS estimate is $0.01 (vs. -$0.01 in the year-ago period) and the consensus revenue estimate is $236.48M (-13% Y/Y). Over the last 2 years, EVH has beaten EPS estima...
News, Short Squeeze, Breakout and More Instantly...
Evolent Health Inc Class A Company Name:
EVH Stock Symbol:
NYSE Market:
2024-04-19 10:47:02 ET Intel Corp. (INTC) INTC is trading DOWN for the last 4 days, and it at trading at $34.86 with volume of 14,560,236 and a one day change of $-0.18 (-0.51%). Intel Corp. has a 52-week low of 26.86 and a 52-week high of $51.28. The business's 50-day moving averag...
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 PR Newswire Company to Participate in Upcoming Conferences WASHINGTON , April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better ...
2024-04-17 14:30:04 ET Piper Sandler analyst issues OVERWEIGHT recommendation for EVH on April 17, 2024 12:15PM ET. The previous analyst recommendation was Overweight. EVH was trading at $29.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...